| ‘Bureaucratic inertia’ over funding for bisphosphonates means thousands miss out Related items from OnMedica Cancer drug access in England is a ‘debacle’ NHS cancer patients still denied treatments available in other countries Radiotherapy during breast cancer surgery cuts cost and time |
Friday 23 September 2016
Women denied cheap drug to stop breast cancer spread
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment